The paper analyzes the overall evolutionary context of the situations of anti-diabetic drug patent applicants at home and abroad and conducts comparative analysis of the main patent applicants, etc. by making use of the patent analysis method and combining pharmaceutical knowledge. Relevant research results can be taken as the references for domestic pharmaceutical enterprises to make patent strategies and evaluate competitors.